ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant DNA (rDNA) Technology Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-13W2743
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant DNA rDNA Technology Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Recombinant DNA (rDNA) Technology Market Research Report 2025

Code: QYRE-Auto-13W2743
Report
June 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis
GenScript
Pfizer Inc
Novo Nordisk A S
Eli Lilly and Company
Sanofi
Biocon Ltd.
GlaxoSmithKline PLC
New England Biolabs
Cibus
Monsanto Company
Horizon Discovery Group plc

Recombinant DNA (rDNA) Technology Market

The global market for Recombinant DNA (rDNA) Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Recombinant DNA (rDNA) Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant DNA (rDNA) Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Recombinant DNA (rDNA) Technology in Biotechnology and Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Recombinant DNA (rDNA) Technology include F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant DNA (rDNA) Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA (rDNA) Technology.
The Recombinant DNA (rDNA) Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant DNA (rDNA) Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant DNA (rDNA) Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Recombinant DNA (rDNA) Technology Market Report

Report Metric Details
Report Name Recombinant DNA (rDNA) Technology Market
Segment by Type
  • Expression System
  • Cloning Vector
Segment by Application
  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, GlaxoSmithKline plc, New England Biolabs., Cibus, Monsanto Company, Horizon Discovery Group PLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Recombinant DNA (rDNA) Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant DNA (rDNA) Technology Market report?

Ans: The main players in the Recombinant DNA (rDNA) Technology Market are F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, GlaxoSmithKline plc, New England Biolabs., Cibus, Monsanto Company, Horizon Discovery Group PLC

What are the Application segmentation covered in the Recombinant DNA (rDNA) Technology Market report?

Ans: The Applications covered in the Recombinant DNA (rDNA) Technology Market report are Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Other

What are the Type segmentation covered in the Recombinant DNA (rDNA) Technology Market report?

Ans: The Types covered in the Recombinant DNA (rDNA) Technology Market report are Expression System, Cloning Vector

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Expression System
1.2.3 Cloning Vector
1.3 Market by Application
1.3.1 Global Recombinant DNA (rDNA) Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic and Government Research Institutes
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA (rDNA) Technology Market Perspective (2020-2031)
2.2 Global Recombinant DNA (rDNA) Technology Growth Trends by Region
2.2.1 Global Recombinant DNA (rDNA) Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Size by Region (2020-2025)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2026-2031)
2.3 Recombinant DNA (rDNA) Technology Market Dynamics
2.3.1 Recombinant DNA (rDNA) Technology Industry Trends
2.3.2 Recombinant DNA (rDNA) Technology Market Drivers
2.3.3 Recombinant DNA (rDNA) Technology Market Challenges
2.3.4 Recombinant DNA (rDNA) Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2020-2025)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2020-2025)
3.2 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant DNA (rDNA) Technology Revenue
3.4 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2024
3.5 Global Key Players of Recombinant DNA (rDNA) Technology Head office and Area Served
3.6 Global Key Players of Recombinant DNA (rDNA) Technology, Product and Application
3.7 Global Key Players of Recombinant DNA (rDNA) Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA (rDNA) Technology Breakdown Data by Type
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Type (2020-2025)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2026-2031)
5 Recombinant DNA (rDNA) Technology Breakdown Data by Application
5.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Application (2020-2025)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2020-2031)
6.2 North America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2020-2031)
7.2 Europe Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size (2020-2031)
8.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant DNA (rDNA) Technology Market Size (2020-2031)
9.2 Latin America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
9.4 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size (2020-2031)
10.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
11.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
11.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
11.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
11.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
11.2 Profacgen
11.2.1 Profacgen Company Details
11.2.2 Profacgen Business Overview
11.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
11.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.2.5 Profacgen Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
11.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.3.5 Amgen Inc Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
11.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.4.5 Novartis AG Recent Development
11.5 GenScript
11.5.1 GenScript Company Details
11.5.2 GenScript Business Overview
11.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
11.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.5.5 GenScript Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Details
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
11.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.6.5 Pfizer Inc Recent Development
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Details
11.7.2 Novo Nordisk A/S Business Overview
11.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
11.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.7.5 Novo Nordisk A/S Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
11.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.8.5 Eli Lilly and Company Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
11.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Biocon
11.10.1 Biocon Company Details
11.10.2 Biocon Business Overview
11.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
11.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.10.5 Biocon Recent Development
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Company Details
11.11.2 GlaxoSmithKline plc Business Overview
11.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
11.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.11.5 GlaxoSmithKline plc Recent Development
11.12 New England Biolabs.
11.12.1 New England Biolabs. Company Details
11.12.2 New England Biolabs. Business Overview
11.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
11.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.12.5 New England Biolabs. Recent Development
11.13 Cibus
11.13.1 Cibus Company Details
11.13.2 Cibus Business Overview
11.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
11.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.13.5 Cibus Recent Development
11.14 Monsanto Company
11.14.1 Monsanto Company Company Details
11.14.2 Monsanto Company Business Overview
11.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
11.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.14.5 Monsanto Company Recent Development
11.15 Horizon Discovery Group PLC
11.15.1 Horizon Discovery Group PLC Company Details
11.15.2 Horizon Discovery Group PLC Business Overview
11.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
11.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025)
11.15.5 Horizon Discovery Group PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis
GenScript
Pfizer Inc
Novo Nordisk A S
Eli Lilly and Company
Sanofi
Biocon Ltd.
GlaxoSmithKline PLC
New England Biolabs
Cibus
Monsanto Company
Horizon Discovery Group plc
List of Tables
 Table 1. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Expression System
 Table 3. Key Players of Cloning Vector
 Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Recombinant DNA (rDNA) Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Recombinant DNA (rDNA) Technology Market Share by Region (2020-2025)
 Table 8. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Recombinant DNA (rDNA) Technology Market Share by Region (2026-2031)
 Table 10. Recombinant DNA (rDNA) Technology Market Trends
 Table 11. Recombinant DNA (rDNA) Technology Market Drivers
 Table 12. Recombinant DNA (rDNA) Technology Market Challenges
 Table 13. Recombinant DNA (rDNA) Technology Market Restraints
 Table 14. Global Recombinant DNA (rDNA) Technology Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Players (2020-2025)
 Table 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2024)
 Table 17. Ranking of Global Top Recombinant DNA (rDNA) Technology Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Recombinant DNA (rDNA) Technology Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Recombinant DNA (rDNA) Technology, Headquarters and Area Served
 Table 20. Global Key Players of Recombinant DNA (rDNA) Technology, Product and Application
 Table 21. Global Key Players of Recombinant DNA (rDNA) Technology, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Recombinant DNA (rDNA) Technology Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2020-2025)
 Table 25. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2026-2031)
 Table 27. Global Recombinant DNA (rDNA) Technology Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2020-2025)
 Table 29. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2026-2031)
 Table 31. North America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 46. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
 Table 47. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
 Table 48. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product
 Table 49. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 50. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
 Table 51. Profacgen Company Details
 Table 52. Profacgen Business Overview
 Table 53. Profacgen Recombinant DNA (rDNA) Technology Product
 Table 54. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 55. Profacgen Recent Development
 Table 56. Amgen Inc Company Details
 Table 57. Amgen Inc Business Overview
 Table 58. Amgen Inc Recombinant DNA (rDNA) Technology Product
 Table 59. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 60. Amgen Inc Recent Development
 Table 61. Novartis AG Company Details
 Table 62. Novartis AG Business Overview
 Table 63. Novartis AG Recombinant DNA (rDNA) Technology Product
 Table 64. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 65. Novartis AG Recent Development
 Table 66. GenScript Company Details
 Table 67. GenScript Business Overview
 Table 68. GenScript Recombinant DNA (rDNA) Technology Product
 Table 69. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 70. GenScript Recent Development
 Table 71. Pfizer Inc Company Details
 Table 72. Pfizer Inc Business Overview
 Table 73. Pfizer Inc Recombinant DNA (rDNA) Technology Product
 Table 74. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 75. Pfizer Inc Recent Development
 Table 76. Novo Nordisk A/S Company Details
 Table 77. Novo Nordisk A/S Business Overview
 Table 78. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product
 Table 79. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 80. Novo Nordisk A/S Recent Development
 Table 81. Eli Lilly and Company Company Details
 Table 82. Eli Lilly and Company Business Overview
 Table 83. Eli Lilly and Company Recombinant DNA (rDNA) Technology Product
 Table 84. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 85. Eli Lilly and Company Recent Development
 Table 86. Sanofi Company Details
 Table 87. Sanofi Business Overview
 Table 88. Sanofi Recombinant DNA (rDNA) Technology Product
 Table 89. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 90. Sanofi Recent Development
 Table 91. Biocon Company Details
 Table 92. Biocon Business Overview
 Table 93. Biocon Recombinant DNA (rDNA) Technology Product
 Table 94. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 95. Biocon Recent Development
 Table 96. GlaxoSmithKline plc Company Details
 Table 97. GlaxoSmithKline plc Business Overview
 Table 98. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product
 Table 99. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 100. GlaxoSmithKline plc Recent Development
 Table 101. New England Biolabs. Company Details
 Table 102. New England Biolabs. Business Overview
 Table 103. New England Biolabs. Recombinant DNA (rDNA) Technology Product
 Table 104. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 105. New England Biolabs. Recent Development
 Table 106. Cibus Company Details
 Table 107. Cibus Business Overview
 Table 108. Cibus Recombinant DNA (rDNA) Technology Product
 Table 109. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 110. Cibus Recent Development
 Table 111. Monsanto Company Company Details
 Table 112. Monsanto Company Business Overview
 Table 113. Monsanto Company Recombinant DNA (rDNA) Technology Product
 Table 114. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 115. Monsanto Company Recent Development
 Table 116. Horizon Discovery Group PLC Company Details
 Table 117. Horizon Discovery Group PLC Business Overview
 Table 118. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product
 Table 119. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2020-2025) & (US$ Million)
 Table 120. Horizon Discovery Group PLC Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Recombinant DNA (rDNA) Technology Picture
 Figure 2. Global Recombinant DNA (rDNA) Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant DNA (rDNA) Technology Market Share by Type: 2024 VS 2031
 Figure 4. Expression System Features
 Figure 5. Cloning Vector Features
 Figure 6. Global Recombinant DNA (rDNA) Technology Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2024 VS 2031
 Figure 8. Biotechnology and Pharmaceutical Companies Case Studies
 Figure 9. Academic and Government Research Institutes Case Studies
 Figure 10. Other Case Studies
 Figure 11. Recombinant DNA (rDNA) Technology Report Years Considered
 Figure 12. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Recombinant DNA (rDNA) Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Recombinant DNA (rDNA) Technology Market Share by Region: 2024 VS 2031
 Figure 15. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2024
 Figure 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2024
 Figure 18. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
 Figure 20. United States Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
 Figure 24. Germany Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Region (2020-2031)
 Figure 32. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
 Figure 40. Mexico Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Country (2020-2031)
 Figure 44. Turkey Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Recombinant DNA (rDNA) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 48. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 49. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 50. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 51. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 52. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 53. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 54. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 55. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 56. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 57. GlaxoSmithKline plc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 58. New England Biolabs. Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 59. Cibus Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 60. Monsanto Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 61. Horizon Discovery Group PLC Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Plasmid DNA Market Research Report 2024
Global Nucleic Acid Nanotechnology Market Research Report 2024
Global Nucleic Acid Based Gene Therapeutics Market Research Report 2024
Global DNA RNA Protection Reagent Market Research Report 2024
Global DNA Biochip Market Research Report 2024
Global circRNA Technology Market Research Report 2024
Global Nucleic Acid Detection Reagents Market Research Report 2024
Global Automated DNA and RNA Synthesizer Market Research Report 2024
Global DNA Reagent Kits Market Research Report 2025
Global DNA Purification Market Research Report 2024
Global DNA and RNA Synthesizers Market Research Report 2024
Global Automated DNA RNA Extractor Market Research Report 2025
Global DNA Vaccination Market Research Report 2024
Global Deoxyribonucleic Acid DNA Purification Market Research Report 2024
Global DNA Synthesis Service Market Research Report 2025
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Acid Sequence Analysis Software Market Research Report 2025
Global Nucleic Acid Testing Market Research Report 2024
Global Automatic Nucleic Acid Detection System Market Research Report 2025
Global DNA Digital Data Storage Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions